Delivery Order 36F79723D0136-36C26124N0192
Award Date
10/6/23
Potential Completion Date
11/6/23
Potential Value
$75K
Federal Agency
Veterans Integrated Service Network 21
Awardee
Amylyx Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
East Cambridge, MA 02141, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration awarded a $93,599.60 delivery order contract to Amylyx Pharmaceuticals Inc., doing business as Amylyx, of Cambridge, Massachusetts. The firm fixed price order is for the delivery of sodium phenylbutyrate and taurursodiol powder oral packets to support VHA's Veterans Integrated Service Network 21. The contract period of performance spans from December 15, 2023 through January 15, 2024. No subcontractors or set aside designations...
<p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 (VA-VHA) awarded a $284,978.20 firm fixed price delivery order contract to Amylyx Pharmaceuticals Inc., doing business as Amylyx, of Cambridge, Massachusetts. The contract term is from June 2, 2023 through September 30, 2023 for the provision of RELYVRIO, a pharmaceutical product, to the VA-VHA. No subcontractors were identified.</p>
Amylyx Pharmaceuticals Inc., doing business as Amylyx, has been awarded a $10,583.64 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 (VA VHA VISN 21) to provide RELYVRIO. The prime contractor Amylyx will deliver the products from its place of performance in Cambridge, Massachusetts between July 27, 2023 and September 27, 2023. No major subcontractors or set aside designations were indicated. This delivery...
Amylyx Pharmaceuticals Inc. was awarded a firm fixed price delivery order for $204,836.65 by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The delivery order is for the provision of RELYVRIO, Amylyx's pharmaceutical treatment for amyotrophic lateral sclerosis, to the place of performance in Cambridge, Massachusetts. The period of performance is from April 1, 2024 through June 30, 2024. Amylyx holds additional vehicles with the VA...
Amylyx Pharmaceuticals Inc. was awarded a $46,799.80 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to provide its amyotrophic lateral sclerosis drug RELYVRIO. The order, issued without a set-aside designation, has a period of performance through May 1, 2024 for delivery to a location in Cambridge, Massachusetts. Amylyx holds several federal vehicles that facilitate provision of its pharmaceutical...
This is a firm-fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Amylyx Pharmaceuticals Inc., doing business as Amylyx, a self-certified small disadvantaged business. The contract, valued at $355,678.72, is for the provision of RELYVRIO, an FDA-approved treatment for amyotrophic lateral sclerosis (ALS), to the Puget Sound VA Medical Center. The contract has an ultimate completion date of March 31, 2023. Amylyx holds several significant Indefinite Delivery...
This federal contract award to Amylyx Pharmaceuticals Inc., doing business as Amylyx, is for the delivery of RELYVRIO Sodium, an FDA-approved treatment for amyotrophic lateral sclerosis (ALS). The $42,334.56 firm-fixed-price delivery order was issued by the Veterans Integrated Service Network 21 (VISN 21), a division of the Department of Veterans Affairs (VA). The contract has no set-aside designation and is intended to supply RELYVRIO to VA medical facilities in the western United States....
This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Amylyx Pharmaceuticals Inc. (Amylyx), a small disadvantaged business. The $250,414.72 firm fixed price contract is for the delivery of RELYVRIO, Amylyx's pharmaceutical product containing sodium phenylbutyrate and taurursodiol, which is indicated for the treatment of amyotrophic lateral sclerosis (ALS). This delivery order was placed against larger...
This is a firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Amylyx Pharmaceuticals Inc., a self-certified small disadvantaged business, for the provision of RELYVRIO, an FDA-approved treatment for amyotrophic lateral sclerosis (ALS). The contract, valued at $44,459.84, was awarded on January 6, 2023, with a completion date of January 31, 2023. Amylyx holds several significant Indefinite Delivery Vehicles (IDVs) with the VA, including a Federal Supply...
This is a firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Amylyx Pharmaceuticals Inc., a self-certified small disadvantaged business. The contract, valued at $10,530.00, is for the provision of RELYVRIO, an FDA-approved treatment for amyotrophic lateral sclerosis (ALS), to the Puget Sound VA Medical Center. The contract has an ultimate completion date of December 21, 2023. Amylyx Pharmaceuticals holds several significant indefinite delivery...